Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 118 of the 120 references it cites were found in a registry or an index.

Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis

Gøtzsche, Peter C. · 1989 · Controlled Clinical Trials

Abstract

Important design aspects were decreasingly reported in NSAID trials over the years, whereas the quality of statistical analysis improved. In half of the trials, the effect variables in the methods and results sections were not the same, and the interpretation of the erythrocyte sedimentation rate in the reports seemed to depend on whether a significant difference was found. Statistically significant results appeared in 93 reports (47%). In 73 trials they favored only the new drug, and in 8 only the active control. All 39 trials with a significant difference in side effects favored the new drug. Choice of dose, multiple comparisons, wrong calculation, subgroup and within-groups analyses, wrong sampling units (in 63% of trials for effect variables, in 23% for side effects), change in measurement scale before analysis, baseline difference, and selective reporting of significant results were some of the verified or possible causes for the large proportion of results that favored the new drug. Doubtful or invalid statements were found in 76% of the conclusions or abstracts. Bias consistently favored the new drug in 81 trials, and the control in only one trial. It is not obvious how a reliable meta-analysis could be done in these trials.

Overview

Integrity signals

Registry

Crossref · 10.1016/0197-2456(89)90017-2

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 120 references

Research works printed but not linked: 3

  1. Ambroz, 1978, Deficiencies of randomized control trials, Clin Res, 26, 280A
  2. Fjellström, 1957, Phenylbutazone in active periods of rheumatoid arthritis, Acta Med Scand (Suppl), 320, 1
  3. Vallance, 1981, Survey of design and analysis of controlled trials of non-steroidal, anti-inflammatory drugs, Aust NZ J Med, 11, 719

Cited by

See all 354

Metadata

Authors
Gøtzsche, P. C.
Affiliations
Hvidovre Hospital (DK)
Corresponding author
Gøtzsche, Peter C.
Venue
Controlled Clinical Trials
Publisher
Elsevier BV
Published
1989-03
Volume
10
Issue
1
Pages
31-56
ISSN
0197-2456 (ISSN-L)
OpenAlex
W1993398606
Cited by
339
References
120
Citations by year
2026: 1 · 2025: 4 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 2 · 2015: 5 · 2014: 6 · 2013: 13 · 2012: 9
FWCI
13.03
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Controlled Clinical Trials (publishedVersion)
  • PubMed (publishedVersion)
Funders
Sundhed og Sygdom, Det Frie Forskningsråd
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
Keywords
nonsteroidal anti-inflammatory drugs, rheumatoid arthritis, publication bias, selective reporting, erythrocyte sedimentation rate, adverse drug reactions, meta-analysis reliability
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal, Arthritis, Rheumatoid, Biological Availability, Blood Sedimentation, Clinical Trials as Topic, Double-Blind Method, Humans, Informed Consent, Patient Compliance, Random Allocation, Research Design, Statistics as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. https://app.cochat.ai/papers/10.1016/0197-2456(89)90017-2
The paper
Gøtzsche, P. C. (1989). Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Controlled Clinical Trials. https://doi.org/10.1016/0197-2456(89)90017-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.